Comparison of three paf-acether receptor antagonist ginkgolides

European Journal of Pharmacology

Volumn 152, Issue 1-2, 1988, Pages 101-110

  Korth, Ruth ^a   Nunez, Danièle ^a   Bidault, Jocelyne ^a   Benveniste, Jacques ^a  

^a INSERM   (France)

Author keywords

BN 52020; BN 52021; BN 52022; BN 52063; Ginkgolides; PAF receptor antagonists; Platelet activating factor (PAF acether, PAF)

Indexed keywords

GINKGOLIDE; GINKGOLIDE A; GINKGOLIDE B; GINKGOLIDE C; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

DOSE RESPONSE; DRUG METABOLISM; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; THROMBOCYTE;

ADENOSINE TRIPHOSPHATE; BINDING, COMPETITIVE; BLOOD PLATELETS; COMPARATIVE STUDY; HUMAN; IN VITRO; LACTONES; MALE; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION; RECEPTORS, CELL SURFACE;

EID: 0023740984     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(88)90840-0     Document Type: Article

References (31)

1. Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils and platelet-activating factor
2. Semi-synthèse et structure proposée du facteur activant les plaquettes (PAF): PAF-acéther, un alkyl ether analogue de la lysophosphatidylcholine
3. Conformational properties of the Paf-acether receptor in platelets based on structure-activity studies
4. Platelet-activating factor - a powerful lipid autacoid possibly involved in microangiopathy
5. Triazolodiazepines: dissociation of their Paf (platelet-activating factor) antagonistic and CNS activity
6. Aggregation of rabbit platelets by platelet-activating factor is independent of the release reaction and the arachidonate pathway and inhibited by membrane active drugs
7. Effectiveness of a specific antagonist of platelet-activating (BN 52063) in man
8. Platelet-activating factor: evidence for 1-O-alkyl-2-acetyl-sn-glycerol-3-phosphorylcholine as the active component (a new class of lipid mediators)
9. Effect of platelet-activating factor on airway vascular permeability: possible mechanisms
10. Inhibition of paf-acether induced weal and flare reaction in man by a specific paf antagonist
11. Specific binding sites for platelet-activating in human lung tissue
12. Biosynthesis of paf-acether (platelet-activating factor). VII. Precursors of paf-acether and acetyl transferase activity in human leukocytes
13. Binding kinetics of paf-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets
14. Kinetics of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine induced fibrinogen binding to human platelets
15. Platelet activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines
16. 3H]paf-acether from, and inhibits its binding to intact human platelets
17. 3H]paf-acether binding
18. Unsaturated platelet-activating factor: Influence on aggregation, serotonin release and thromboxane synthesis of human thrombocytes
19. Inhibition by ticlopidine of paf-acether-induced in vitro aggregation of rabbit and human platelets
20. Kadsurenone distinguishes between different platelet-activating factor receptor subtypes on macrophages and polymorphonuclear leucocytes
21. Specific inhibition of paf-acether-induced platelet activation by BN 52021 and comparison with the paf-acether inhibitors Kadsurenone and CV 3988
22. Binding and metabolism of platelet-activating factor by human neutrophils
23. Chemistry and biology of acetyl glyceryl ether phopshorylcholine (platelet-activating factor)
24. Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): Specific inhibition of in vitro and in vivo platelet-activating factor-induced effects
25. Chemical and biochemical aspects of platelet-activating factor: a novel class of acetylated ether-linked choline-phospholipids
26. CV 3988, a specific antagonist of platelet-activating factor (PAF)
27. Specific binding of phospholipid platelet-activating factor by human platelets
28. Specific binding by human polymorphonuclear leucocytes of the immunological mediator 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphocholine
29. Background and present status of research on platelet-activating factor (Paf-acether)
30. 3H]paf-acether binding to washed human platelets
31. Platelet-activating factor: A potent chemotactic and chemokinetic factor for human eosinophils